Company Filing History:
Years Active: 2023
Title: **Karin Gerola: Innovator in Pharmaceutical Liquid Suspensions**
Introduction
Karin Gerola, an accomplished inventor based in Nyon, Switzerland, has made significant contributions to the field of pharmaceuticals. With a keen focus on improving the effectiveness and stability of over-the-counter medications, she holds a patent that showcases her innovative spirit and expertise in formulation science.
Latest Patents
Karin Gerola's notable patent involves the formulation of pharmaceutical liquid suspensions containing paracetamol. The patent describes a unique formulation where paracetamol particles are characterized by a d50 of less than or equal to 10 µm and a d90 of less than or equal to 35 µm. This innovative approach aims to minimize browning discoloration during prolonged storage, thereby enhancing the product's shelf life and overall quality. Her work contributes to the ongoing development of safer and more efficient medicinal products.
Career Highlights
Karin is currently associated with GSK Consumer Healthcare Sàrl, where she applies her expertise to bring innovative health solutions to the market. Her career is marked by her dedication to research and development in the consumer healthcare sector, focusing on creating formulations that improve patient outcomes. With one patent to her name, Karin has established herself as a key player in pharmaceutical innovation.
Collaborations
In her pursuit of advancement in pharmaceuticals, Karin collaborates with esteemed professionals such as Mauro Cavinato. Their partnership highlights the importance of teamwork in fostering innovation and developing new products that meet consumer needs. Through these collaborations, they continue to push the boundaries of what is possible in the field of pharmaceutical sciences.
Conclusion
Karin Gerola's journey as an inventor reflects her passion for improving health outcomes through innovative solutions. Her patent on paracetamol liquid suspensions not only demonstrates her technical prowess but also her commitment to quality in the pharmaceutical industry. As she continues to work with GSK Consumer Healthcare Sàrl, her contributions are expected to have a lasting impact on the field of medicines.